Alemtuzumab induction versus conventional immunosuppression in heart transplant recipients

被引：0
|
作者：
Leelathanalerk, Areerut [1 ]
Ingviya, Thammasin [2 ]
Ivaturi, Vijay [1 ]
Reed, Brent N. [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA
来源：
PHARMACOTHERAPY | 2015年 / 35卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
451
引用
收藏
页码：E292 / E293
页数：2
相关论文
共 50 条
  • [41] Alemtuzumab induction therapy in HIV-positive renal transplant recipients
    Mclean, Florence E.
    Gathogo, Esther
    Goodall, Dawn
    Jones, Rachael
    Kinlcoh, Sabine
    Post, Frank A.
    AIDS, 2017, 31 (07) : 1047 - 1048
  • [42] Alemtuzumab Induction is Effective and Safe in Elderly Kidney Transplant Recipients.
    Toledo, A.
    Szempruch, K.
    Serrano, P.
    Andreoni, K.
    Kozlowski, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 678 - 678
  • [43] Evaluation of the Efficacy and Safety of Dual Induction versus Induction Monotherapy in Orthotopic Heart Transplant Recipients
    Sterling, S.
    Soto-Arenall, M.
    Goswami, R.
    Patel, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S276 - S276
  • [44] Short course induction immunosuppression with thymoglobulin for renal transplant recipients
    Agha, IA
    Rueda, J
    Alvarez, A
    Singer, GG
    Miller, BW
    Flavin, K
    Lowell, JA
    Shenoy, S
    Howard, TK
    Ramachandran, V
    Irish, W
    Schnitzle, MA
    Brennan, DC
    TRANSPLANTATION, 2002, 73 (03) : 473 - 475
  • [45] Evaluation of Induction Immunosuppression in Elderly Kidney Transplant Recipients.
    Pham, C.
    Kuten, S.
    Rogers, A.
    Knight, R.
    Nguyen, D. T.
    Graviss, E.
    Gaber, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 824 - 824
  • [46] Induction Immunosuppression in High-risk Kidney Transplant Recipients
    Buttigieg, Jesmar
    Bridson, Julie M.
    Sharma, Ajay
    Halawa, Ahmed
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (04) : 367 - 376
  • [47] Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?
    Agrawal, Akansha
    Stosor, Valentina
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (04)
  • [48] A contemporary analysis of induction immunosuppression in pediatric lung transplant recipients
    Hayes, Don, Jr.
    Kirkby, Stephen
    Wehr, Allison M.
    Lehman, Amy M.
    McConnell, Patrick I.
    Galantowicz, Mark
    Higgins, Robert S.
    Whitson, Bryan A.
    TRANSPLANT INTERNATIONAL, 2014, 27 (02) : 211 - 218
  • [49] Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience
    Yakubu, Idris
    Ravichandran, Bharath
    Sparkes, Tracy
    Barth, Rolf N.
    Haririan, Abdolreza
    Masters, Brian
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (02) : 199 - 206
  • [50] Prospective pilot study of sirolimus as an induction of immunosuppression in heart transplant recipients - Three year results.
    Zakliczynski, MW
    Krynicka, A
    Nozynski, J
    Trybunia, D
    Zembala, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 244 - 244
12345